Building Africa's next generation of healthcare, AI, sustainability & digital safety ventures.
We transform bold ideas into scalable ventures reaching 50,000+ lives — identifying critical challenges, validating solutions in real-world environments, and commercializing what works.
0
Active Ventures
0
Focus Sectors
0
Markets Targeted
0+
Lives Reached
Operating across
Jimoh Habibullahi
Founder & Innovation Lead
Jimoh Habibullahi — Founder
Jimoh Habibullahi is a healthcare innovator, entrepreneur, AI advocate, and venture builder dedicated to developing scalable technology solutions across healthcare, sustainability, public health, and digital safety. Through CYTOBIZ Group Solutions Lab, he leads the development, validation, and commercialization of transformative ventures addressing critical challenges across Africa and emerging markets.
Innovation
Methodology
Pioneered the CYTOBIZ venture-building framework spanning seven stages from problem discovery to scale.
Ventures
13 Active Builds
Healthcare AI, telemedicine, sustainability and digital safety ventures actively in build.
Impact
Africa-First
Designs solutions for African realities — local data, local languages, local clinical context.
Leadership
Multidisciplinary
Brings together clinicians, engineers, designers and policy experts under one lab.
A portfolio engineered for measurable, scalable impact.
Portfolio composition
Ventures by sector
Active Ventures
0
Healthcare Innovations
0
AI Solutions
0
Sustainability Projects
0
Digital Safety
0
Lives Reached
0+
Investment Thesis
Africa's healthcare, AI, and sustainability infrastructure will be built in the next decade — by the founders building it now.
- → Multi-sector platform exposure
- → Validated in real-world African contexts
- → Scalable to global emerging markets
- → Founder-aligned governance
Field moments, demos, and product proof from the portfolio.
VisionGuard AI
Community pharmacy screening — Lagos, Nigeria
VisionGuard AI
Field deployment with the VisionGuard AI team
Vitalens
Vitalens device demo by the founding team
SureDose
SureDose adherence app — treatment plan UI
SureDose
Adherence kits distributed in the field
SureDose
SureDose business model — pitch session
A seven-stage venture studio process — from a real problem to a scaled, commercialized solution.
Problem Discovery
Field research with patients, clinicians, and operators across emerging markets.
Research & Validation
Evidence-driven assessment of feasibility, ethics, regulation, and market shape.
Solution Design
Multidisciplinary teams craft solutions with founders, scientists, and designers.
Prototype Development
Build fast, instrument everything, and learn from the first cohort of users.
Pilot Testing
Real-world pilots with hospital, government, and NGO partners.
Market Entry
Productize, secure regulatory clearance, and launch with anchor customers.
Scale & Commercialization
Capital formation, geographic expansion, and platform infrastructure.
Solutions built for transformative impact.
Four products have reached early traction.
Reached
VisionGuard AI
Reached
CYTOBIZ Academy
Reached
CYTOBIZ MedicalMarket
Reached
SureDose
Trusted by leading hubs, universities, hospitals, and innovation partners.
Our ventures are validated and supported by an ecosystem of institutional partners across academia, healthcare, and innovation.
Backing the next decade of African healthcare and AI.
We work with investors, governments, hospitals, NGOs, universities, and operators. Let's design what comes next.